These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3145343)

  • 21. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    Machka K; Dietz R
    Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bactericidal activities of isepamicin and ofloxacin against Pseudomonas aeruginosa evaluated using an in vitro pharmacokinetic simulation system].
    Tsuji A; Kaneko Y; Yamaguchi K; Goto S
    Jpn J Antibiot; 1994 Aug; 47(8):1006-12. PubMed ID: 7933530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
    Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
    Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
    Valiant ME; Gilfillan EC; Gadebusch HH; Pelak BA
    J Antibiot (Tokyo); 1989 May; 42(5):807-14. PubMed ID: 2498278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa.
    Mukherjee S; Chaki S; Das S; Sen S; Dutta SK; Dastidar SG
    Indian J Exp Biol; 2011 Jul; 49(7):547-51. PubMed ID: 21800506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa. In vitro synergistic activities].
    Iyama Y; Sato K; Okachi R
    Jpn J Antibiot; 1985 Apr; 38(4):1022-8. PubMed ID: 3928940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo effects of combinations of cefotaxime or other beta-lactams with rolitetracycline on methicillin-resistant Staphylococcus aureus.
    Kobayashi S; Arai S; Hayashi S
    Jpn J Antibiot; 1989 May; 42(5):1208-15. PubMed ID: 2746860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
    Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Mocchegiani F; Chiodi L; Castelletti S; Gabrielli E; Saba V; Scalise G; Giacometti A
    J Antimicrob Chemother; 2008 Dec; 62(6):1332-8. PubMed ID: 18799470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
    Hagens S; Habel A; Bläsi U
    Microb Drug Resist; 2006; 12(3):164-8. PubMed ID: 17002542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of the combined treatment with isepamicin and piperacillin in an in vitro model for complicated cystitis operated by automatic simulator apparatus for urinary concentration].
    Nishimura M; Kumamoto Y; Hirose T; Shibuya A; Tsukamoto T; Ohya S
    Kansenshogaku Zasshi; 1992 Jan; 66(1):6-13. PubMed ID: 1402064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic synergy: clinical applications and an in vitro study of cefotaxime-aminoglycoside combinations.
    Faris HM; Dreskin RB
    J S C Med Assoc; 1983 May; 79(5):275-7. PubMed ID: 6308348
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
    Jerzsele Á; Pásztiné-Gere E
    Acta Microbiol Immunol Hung; 2015 Mar; 62(1):45-55. PubMed ID: 25823453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.
    Christensen LD; van Gennip M; Jakobsen TH; Alhede M; Hougen HP; Høiby N; Bjarnsholt T; Givskov M
    J Antimicrob Chemother; 2012 May; 67(5):1198-206. PubMed ID: 22302561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined action of semisynthetic penicillin and macrolide antibiotic on Pseudomonas aeruginosa in vitro and in vivo.
    Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1979 Oct; 49(5):331-6. PubMed ID: 119075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 2. The results against enterobacteriaceae].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 Mar; 49(3):279-88. PubMed ID: 8935124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.